Brachytherapy Market Size Worth USD 670.92 Billion in 2032 | Emergen Research

Rising incidence of cancer is one of the most significant factors influencing the brachytherapy market growth.

Vancouver, Dec. 04, 2023 (GLOBE NEWSWIRE) — The global brachytherapy market is projected to be worth USD 670.92 Million by 2032, according to a current analysis by Emergen Research. The brachytherapy market is experiencing an increased demand attributed to its growing application in the treatment of cancer. Cancer has a significant impact on global society. According to the statistics published by the National Cancer Institute, about 1,806,590 new cancer cases will be diagnosed in the US in 2020 and will account for the death of 606,520 individuals. In 2020, prostate, colorectal, and lung cancers will be responsible for a projected 43.0% diagnosed cases in men. On the other hand, breast, colorectal, and lung cancer are the most common causes of cancer in women and will be responsible for a projected 50.0% of diagnosed cases.

Technological advancements such as the development of novel radioactive sources, remote after-loading systems, innovations in 3D imaging methods, computerized treatment methods, and clinical trials in brachytherapy are significant factors driving the market growth. Groundbreaking technologies are being embraced to assist in creating personalized solutions for challenging conditions to deliver enhanced brachytherapy procedures to help in cancer treatment.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/183

Scope of Research

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/183

MAJOR COMPANIES and Competitive Landscape

The leading players in the brachytherapy market are equipped with enhanced production facilities and are involved in various R&D activities.

A few leading players in the brachytherapy market include:

• Elekta AB
• CR Bard Inc.
• Varian Medical Systems Inc.
• Eckert & Ziegler BEBIG SA
• CIVCO Medical Solutions
• iCAD Inc.
• Isoray Medical Inc.
• Sun Nuclear Corporation
• Theragenics Corporation
• Huiheng Medical Inc.

Strategic Development

• In April, 2020, Elekta announced the introduction of a universal gynecological brachytherapy applicator, Geneva, which was designed deploying the outside-in methodology of Elekta, which caters to the growing needs of front-line cancer therapists.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/183

Key Highlights from The Report

• Low-dose rate (LDR) brachytherapy is likely to grow at the fastest rate of x% in the forecast period. The radioactive sources, in LDR, are placed inside or directly beside the tumor and may be left in the target location permanently. Prostate cancer is the most commonly treated condition using Low dose rate brachytherapy.
• Breast cancer is the most commonly occurring cancer type in women, with more than 2 million new breast cancer cases in 2018. The global breast cancer survival rates vary greatly, ranging from around 80% in North America, Japan, and Sweden to nearby 60% in middle-income nations and lower than 40% in low-income nations.
• Specialty clinics are equipped with the requisite radiotherapy instrument & devices and specialist staff to assist in diagnosing cancer and adopting a suitable procedure for disease treatment.
• The brachytherapy market in the Asia Pacific region is likely to grow at the fastest rate of 5.6% in the forecast period due to the growing incidence and occurrence of cancer, the increasing prevalence of health insurance, and improving reimbursement policies.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/brachytherapy-market

Emergen Research has segmented the global brachytherapy market on the basis of type, application, end-users, and region:

• Type Outlook (Revenue, USD Billion; 2019-2032)
  • High Dose Rate (HDR) Brachytherapy
  • Low Dose Rate (LDR) Brachytherapy
  • Others
• Application Outlook (Revenue, USD Billion; 2019-2032)
  • Prostate Cancer
  • Gynecological Cancer
  • Breast Cancer
  • Skin Cancer
  • Others
• End Users Outlook (Revenue, USD Billion; 2019-2032)
  • Hospitals
  • Specialty Clinics
  • Others
• Regional Outlook (Revenue, USD Billion; 2019-2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. BENELUX
    5. Rest of Europe
  • Asia Pacific
    1. China
    2. Japan
    3. South Korea
    4. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • MEA
    1. Saudi Arabia
    2. UAE
    3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Contact Lenses Market By Usage (Daily Wear, Extended Wear, Traditional Lenses), By Design (Monovision, Spherical, Toric, Multifocal), By Material (Hybrid, Silicone Hydrogel, Rigid Gas Permeable, PMMA), By Application (Therapeutic, Lifestyle-Oriented, Prosthetic, Cosmetic, Corrective), By Marketing Channel (Online, Offline), and By Region Forecast to 2028

Near Infrared Imaging Market By Type, By Application (Oncology, Preclinical Imaging, Gastrointestinal Surgeries, Others), By End-use (Hospitals, Molecular Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Others), By Region Forecast To 2030

In Situ Hybridization Market, By Technology (Fluorescence In-Situ Hybridization), By Product (Kits and Reagents, Probes), By Application (Cancer Diagnosis, Immunology) By End-Use (Hospitals, Diagnostic Centers), and By Region Forecast to 2030

Nanotechnology Market, By Type (Nanosensors, Nanodevice, Nanomaterials, Others), By Application (Information Technology (IT), Homeland Security, Medicine, Transportation, Food Safety, Others), By End-use, and By Region Forecast to 2030

Orthopedic Biomaterial Market By Material Type (Polymers, Ceramics & Bioactive Glasses, Composites, Metal, Calcium Phosphate), By Application (Orthopedic Implants, Orthobiologics, Joint Reconstruction/Replacement, Bio-resorbable Tissue Fixation, Visco Supplementation), By End-Use (Hospitals, Specialty Clinics, Ambulatory Surgical Centers), and By Region, Forecast to 2028

Laboratory Centrifuges Market By Product (Equipment, Accessories), By Model (Benchtop Centrifuges, Floor-standing Centrifuges), By Usage (General Purpose Centrifuges, Preclinical Centrifuges, Clinical Centrifuges), By Rotor Design (Fixed-angle Rotors, Vertical Rotors, Swinging-bucket Rotors, Other Rotors), By Application (Diagnostics, Cellomics, Genomics, Microbiology, Blood Component Separation, Proteomics, Other), By End-Use (Hospitals, Academic & Research Institutions, Biotechnology & Pharmaceutical Companies), and By Region Forecast to 2028

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Brachytherapy Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-brachytherapy-market